To further identify the key molecular targets of lenvatinib in ICC, clustering analysis was performed, and the results showed that the lenvatinib and control groups could clearly be distinguished according to the differentially expressed genes, with significant Gadd45a upregulation detected in the lenvatinib-treated groups (Fig. 4a–c). Here, GADD45A is linked to intrahepatic cholangiocarcinoma.